Cidara Therapeutics Raises $42M

San Diego-based Cidara Therapeutics, which is developing treatments for fungal and other infections, has raised $42M in a Series B funding. Names of the investors were not announced. Cidara said the funding came from a syndicate of healthcare-dedicated institutional investors, and both new and existing investors. Cidara Therapeutics is developing biotechnology products in the anti-infective and immunotherapy areas. The company is led by Jeff Stein. More information »